NXPI vs RAPT · P/E 29, rev $12.27B vs $132.1M cap
NXP Semiconductors NV (NXPI) versus RAPT Therapeutics Inc (RAPT) — a side-by-side from cached financials, not a winner call.
NXP Semiconductors NV (NXPI) is a semiconductors company listed on NASDAQ.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Latest reported NXPI revenue for 2025-12-31 was $12.27B. Net income was $2.02B. Revenue was down 2.7% from 2024-12-31 to 2025-12-31. NXPI currently screens at market cap $76.47B and trailing P/E 29.0.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
NXPI currently screens at market cap $76.47B and trailing P/E 29.0. RAPT currently screens at market cap $132.1M.
Not investment advice. Open the NXPI and RAPT stock pages for the full models.
Not investment advice.